Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bray

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Pharmacogenetics and Genomics|January 7, 2010
HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphismsRuben C Hartkoorn, Wai San Kwan, Victoria Shallcross, et al.
Angewandte Chemie (International Ed. in English)|August 13, 2004
Design and synthesis of endoperoxide antimalarial prodrug modelsPaul M O'Neill, Paul A Stocks, Matthew D Pugh, et al.
The EMBO Journal|June 10, 2005
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistanceViswanathan Lakshmanan, Patrick G Bray, Dominik Verdier-Pinard, et al.
Molecular Microbiology|September 8, 2006
PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IXPatrick G Bray, Mathirut Mungthin, Ian M Hastings, et al.
Journal of Medicinal Chemistry|February 20, 2004
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisininJ Prince Jeyadevan, Patrick G Bray, James Chadwick, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2009
Plasmodium falciparum and dihydrofolate reductase I164L mutations in AfricaAlisa P Alker, Jonathan J Juliano, Steven R Meshnick, et al.
Angewandte Chemie (International Ed. in English)|July 21, 2007
Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugsPaul A Stocks, Patrick G Bray, Victoria E Barton, et al.
Journal of Medicinal Chemistry|October 31, 2003
Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarialsPaul M O'Neill, Amira Mukhtar, Paul A Stocks, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Antitumour and antimalarial activity of artemisinin-acridine hybridsMichael Jones, Amy E Mercer, Paul A Stocks, et al.
Angewandte Chemie (International Ed. in English)|July 15, 2010
Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisininsPaul M O'Neill, Richard K Amewu, Gemma L Nixon, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Pharmacogenetics and Genomics|January 7, 2010
HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphismsRuben C Hartkoorn, Wai San Kwan, Victoria Shallcross, et al.
Angewandte Chemie (International Ed. in English)|August 13, 2004
Design and synthesis of endoperoxide antimalarial prodrug modelsPaul M O'Neill, Paul A Stocks, Matthew D Pugh, et al.
The EMBO Journal|June 10, 2005
A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistanceViswanathan Lakshmanan, Patrick G Bray, Dominik Verdier-Pinard, et al.
Molecular Microbiology|September 8, 2006
PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IXPatrick G Bray, Mathirut Mungthin, Ian M Hastings, et al.
Journal of Medicinal Chemistry|February 20, 2004
Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisininJ Prince Jeyadevan, Patrick G Bray, James Chadwick, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2009
Plasmodium falciparum and dihydrofolate reductase I164L mutations in AfricaAlisa P Alker, Jonathan J Juliano, Steven R Meshnick, et al.
Angewandte Chemie (International Ed. in English)|July 21, 2007
Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugsPaul A Stocks, Patrick G Bray, Victoria E Barton, et al.
Journal of Medicinal Chemistry|October 31, 2003
Isoquine and related amodiaquine analogues: a new generation of improved 4-aminoquinoline antimalarialsPaul M O'Neill, Amira Mukhtar, Paul A Stocks, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Antitumour and antimalarial activity of artemisinin-acridine hybridsMichael Jones, Amy E Mercer, Paul A Stocks, et al.
Angewandte Chemie (International Ed. in English)|July 15, 2010
Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisininsPaul M O'Neill, Richard K Amewu, Gemma L Nixon, et al.
Pageof 17